17 patents
Utility
Novel Iron Compositions and Methods of Making and Using the Same
4 Jan 24
The present invention involves a novel aqueous iron composition.
Donald Jeffrey KEYSER, Alvaro F. GUILLEM, Richard A. ZAGER
Filed: 7 Sep 23
Utility
Iron compositions and methods of making and using the same
12 Dec 23
The present invention involves a novel aqueous iron composition.
Donald Jeffrey Keyser, Alvaro F. Guillem, Richard A. Zager
Filed: 15 Feb 22
Utility
Iron compositions and methods of making and using the same
5 Dec 23
The present invention involves a novel aqueous iron composition.
Donald Jeffrey Keyser, Alvaro F. Guillem, Richard A. Zager
Filed: 2 Nov 22
Utility
Methods of Treating Patients at Risk for Renal Injury and Renal Failure
5 Oct 23
The p21 biomarker is utilized in the evaluation of whether a patient is suffering from kidney injury or failure, and can be used in methods of treating kidney injury or failure by determining the appropriateness of one or more of initiating renal replacement therapy, withdrawing delivery of compounds that are known to be damaging to the kidney, delaying or avoiding procedures that are known to be damaging to the kidney, and modifying diuretic administration.
Richard A. ZAGER, Donald Jeffrey KEYSER, Alvaro F. GUILLEM
Filed: 26 Jul 22
Utility
Novel Iron Compositions and Methods of Making and Using the Same
9 Mar 23
The present invention involves a novel aqueous iron composition.
Donald Jeffrey KEYSER, Alvaro F. GUILLEM, Richard A. ZAGER
Filed: 2 Nov 22
Utility
Metal Protoporphyrin for Treatment of BK Virus
26 Jan 23
The inactivation of BK virus in patients diagnosed with BK virus, those receiving a kidney that is infected or suspected of being infected by BK virus, or in the transplanted kidney before, during, and/or after transplant surgery is described.
Donald Jeffrey Keyser, Alvaro F. Guillem, Bhupinder Singh, Stacey Ruiz
Filed: 8 Jul 22
Utility
Methods of treating patients at risk for renal injury and renal failure
6 Sep 22
The p21 biomarker is utilized in the evaluation of whether a patient is suffering from kidney injury or failure, and can be used in methods of treating kidney injury or failure by determining the appropriateness of one or more of initiating renal replacement therapy, withdrawing delivery of compounds that are known to be damaging to the kidney, delaying or avoiding procedures that are known to be damaging to the kidney, and modifying diuretic administration.
Richard A. Zager, Donald Jeffrey Keyser, Alvaro F. Guillem
Filed: 24 May 19
Utility
Novel Iron Compositions and Methods of Making and Using the Same
4 Aug 22
The present invention involves a novel aqueous iron composition.
Donald Jeffrey KEYSER, Alvaro F. GUILLEM, Richard A. ZAGER
Filed: 15 Feb 22
Utility
Iron compositions and methods of making and using the same
5 Apr 22
The present invention involves a novel aqueous iron composition.
Donald Jeffrey Keyser, Alvaro F. Guillem, Richard A. Zager
Filed: 28 Feb 20
Utility
Method for Treating Cancer with Kidney Protection
17 Mar 22
The present invention involves a novel method for treatment of cancer that involves co-administration of iron sucrose and/or a protoporphyrin such as tin protoporphyrin in an amount sufficient to protect a patient's kidney against cytotoxicity of a chemotherapeutic agent.
Donald Jeffrey Keyser, Alvaro F. Guillem, Richard A. Zager
Filed: 13 Sep 21
Utility
Method for Treatment of Coronavirus Infection
4 Nov 21
The present invention involves a novel method for treatment of coronavirus infection, including SARS-COV-2.
Donald Jeffrey KEYSER, Alvaro F. GUILLEM, Bhupinder SINGH, Richard A. ZAGER, Stacey RUIZ
Filed: 18 Mar 21
Utility
Stress Test and Treatment of Chronic Kidney Disease
21 Oct 21
The present invention involves a novel method for treatment of chronic kidney disease comprising administering a compound that induces a stress protein response in a patient, and administering a potent antioxidant if the patent's response is below a predefined level.
Donald Jeffrey KEYSER, Alvaro F. GUILLEM, Bhupinder SINGH, Richard A. ZAGER
Filed: 23 Mar 21
Utility
CorrectedNovel Tetrahydrocurcumin Compositions, Methods of Making, and Methods of Using the Same
7 Oct 21
The present invention relates to novel tetrahydrocurcumin (THCu) compositions, novel methods of manufacturing, and methods of using these compositions for therapeutic applications.
Donald Jeffrey KEYSER, Alvaro F. GUILLEM, Bhupinder SINGH, Richard A. ZAGER
Filed: 6 Mar 20
Utility
Novel Tetrahydrocurcumin Compositions, Methods of Making, and Methods of Using the Same
9 Sep 20
The present invention relates to novel tetrahydrocurcumin (THCu) compositions, novel methods of manufacturing, and methods of using these compositions for therapeutic applications.
Donald Jeffrey KEYSER, Alvaro F. GUILLEM, Bhupinder SINGH, Richard A. ZAGER
Filed: 5 Mar 20
Utility
Novel Iron Compositions and Methods of Making and Using the Same
2 Sep 20
The present invention involves a novel aqueous iron composition.
Donald Jeffrey KEYSER, Alvaro F. GUILLEM, Richard A. ZAGER
Filed: 27 Feb 20
Utility
Methods for Treating Renal Injury by Therapeutically Upregulating P21
3 Jun 20
The present invention relates to methods for treating acute kidney injury that utilize a glucocorticoid prodrug.
Richard A. ZAGER, Donald Jeffrey KEYSER, Alvaro F. GUILLEM
Filed: 26 Nov 19
Utility
Methods of Treating Patients at Risk for Renal Injury and Renal Failure
19 Feb 20
The p21 biomarker is utilized in the evaluation of whether a patient is suffering from kidney injury or failure, and can be used in methods of treating kidney injury or failure by determining the appropriateness of one or more of initiating renal replacement therapy, withdrawing delivery of compounds that are known to be damaging to the kidney, delaying or avoiding procedures that are known to be damaging to the kidney, and modifying diuretic administration.
Richard A. ZAGER, Donald Jeffrey KEYSER, Alvaro F. GUILLEM
Filed: 23 May 19
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first